Evidence map›Paper›PMID 42064295›Full record

ReviewInfection and drug resistance2026

Antimicrobial Resistance in Refugee Camps and Prisons: A Global Scoping Review of Primary Studies on Burden, Risk Factors, Surveillance, and Mitigation Strategies.

Egide Ndayambaje, Olivier Sibomana, Marvellous Asika, Grace Marie Uwizeyimana, Gabriel Oke, Leonard Ighodalo Uzairue, Darius Benimana

Abstract readReview
In one paragraph

Review in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Egide NdayambajeDepartment of Research, OLGnova, Kigali, Rwanda.ORCID 0009-0006-3391-7378
Olivier SibomanaDepartment of Research, OLGnova, Kigali, Rwanda.ORCID 0000-0003-2226-3883
Marvellous AsikaSociety for Disease Prevention Inc, Houston, TX, USA.
Grace Marie UwizeyimanaDepartment of General Medicine and Surgery, University of Rwanda, Kigali, Rwanda.
Gabriel OkeDepartment of Research, OLGnova, Kigali, Rwanda.
Leonard Ighodalo UzairueDepartment of Research, OLGnova, Kigali, Rwanda.
Darius BenimanaDepartment of General Medicine and Surgery, University of Rwanda, Kigali, Rwanda.ORCID 0009-0007-7113-8073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: AMR is a global health threat, and prisons and refugee camps are high-risk environments for the acquisition and spread of multidrug-resistant organisms (MDROs). This scoping review aims to map the existing evidence on antimicrobial resistance (AMR) in prisons and refugee camps, focusing on burden, risk factors, surveillance, resistance patterns, and mitigation strategies. Methods: The scoping review followed the Arksey and O'Malley methodology and adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR) checklist. Using predefined search terms related to AMR, literature was identified through searches of SCOPUS, PubMed/MEDLINE, Google Scholar, the Directory of Open Access Journals (DOAJ), and grey literature sources, including reports from the World Health Organization (WHO) and the United Nations High Commissioner for Refugees (UNHCR). The literature was screened based on inclusion and exclusion criteria to select relevant studies. Studies were screened based on predefined inclusion and exclusion criteria, and data were extracted into Microsoft Excel for descriptive and thematic analysis. Results: From 3659 records identified at the initial search, 26 primary studies from 18 countries met the inclusion criteria. Most studies addressed AMR burden (65.4%), followed by risk factors (26.9%), while surveillance and mitigation strategies were each addressed in 3.8% of studies. Key themes were categorized as primary focus, while additional themes were recorded as secondary focus areas. Overall, the studies reported a high prevalence of multidrug-resistant organisms. MRSA colonization reached 15.7% in Swiss refugee canters and 21.3% in Finnish cohorts, while ESBL carriage was as high as 32.9%. Additionally, multidrug-resistant tuberculosis (MDR-TB) prevalence reached 9.5% in Ethiopian prisons. Risk factors included prior hospitalization, self-medication, prolonged antibiotic exposure, treatment interruptions, overcrowding, and poor hygiene Surveillance efforts were limited, and evidence on mitigation strategies was scarce, with only two studies describing antimicrobial stewardship program (ASP) implementation in prison settings in Italy and the United States. Conclusion: The review shows that overcrowding, inadequate sanitation, interrupted healthcare, and poor stewardship are the main causes of the high incidence of AMR in prison and refugee camps. To protect these susceptible groups and stop the spread of AMR worldwide, it is critically necessary to improve surveillance, infection control, and context-specific mitigation techniques.

Indexed as

antimicrobial resistanceprisonsrefugee camps

Identifiers

PMID42064295
PMCPMC13127435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.